Skip to main content

Animations

MJFF Publications

5151 - 5160 of 7942 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • RESTRICTED
    Title: Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-09613-z
    Citation Count: 150
  • OPEN
    Title: Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27659
    Citation Count: 283
  • RESTRICTED
    Title: Progressive loss of raphe nuclei serotonin transporter in early Parkinson's disease: A longitudinal 123I-FP-CIT SPECT study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.03.025
    Best OA location URL:
    Citation Count: 34
  • OPEN
    Title: Heritability and genetic variance of dementia with Lewy bodies
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.04.004
    Citation Count: 35
  • OPEN
    Title: Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson’s Disease
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.8b00982
    Citation Count: 55
  • OPEN
    Title: Impact of Pre-Analytical Differences on Biomarkers in the ADNI and PPMI Studies: Implications in the Era of Classifying Disease Based on Biomarkers
    Journal Name: Journal of Alzheimer's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jad-190069
    Citation Count: 15
  • OPEN
    Title: Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2019.01.011
    Citation Count: 42
  • OPEN
    Title: The sncRNA Zoo: a repository for circulating small noncoding RNAs in animals
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/nar/gkz227
    Citation Count: 9
  • OPEN
    Title: Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.01.021
    Citation Count: 22
  • RESTRICTED
    Title: Distinct Missense Mutations of the Parkinson's Disease‐Related Ubiquitin Kinase PINK1 Alter Auto‐ or Substrate‐Phosphorylation
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fasebj.2019.33.1_supplement.lb329
    Best OA location URL:
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.